- Location
chronic weight management
"-
Vivus Has Revealed The Initial Availability of Qsymia Capsules CIV in 8,000 Walgreens
Jul 9, 2013Vivus has revealed the initial availability of Qsymia (phentermine and topiramate extended-release) capsules CIV in 8,000 Walgreens, Costco and Duane Reade retail pharmacies in the US. Qsymia is indicated as an adjunct to a ...
Tags: Qsymia, Pharmacies, Vivus
-
Eisai Has Announced The Availability of Belviq (Lorcaserin HCl) CIV Tablets in The US
Jun 13, 2013Eisai has announced the availability of Belviq (lorcaserin HCl) CIV tablets in the US, which is designed for chronic weight management in adults who are overweight with a comorbidity or obesity. Indicated for people with body mass ...
Tags: Eisai, Weight Management Therapy
-
Eisai Laboratorios Has Submitted a Marketing Authorization Application for Belviq
Apr 3, 2013Eisai's subsidiary Eisai Laboratorios has submitted a marketing authorization application (MAA) for Belviq (lorcaserin HCl) with the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico. Arena Pharmaceuticals's ...
Tags: Eisai, Mexican Marketing, Belviq
-
Arena Pharmaceuticals and Eisai Have Announced FDA Approval of Belviq
Dec 5, 2012Arena Pharmaceuticals and Eisai have announced FDA approval of Belviq (lorcaserin HCl) for chronic weight management in adults who are overweight with comorbidity or obese. The FDA approved Belviq as an adjunct to a reduced-calorie diet ...
Tags: Belviq, lorcaserin HCl, chronic weight management, Arena Pharmaceuticals
-
Catalent Has Signed a Supply Agreement with Vivus
Nov 28, 2012Catalent Pharma Solutions has signed a supply agreement with Vivus to supply Qsymia capsules, a proprietary combination phentermine and extended-release topiramate. Catalent Modified Release Technologies president Ian Muir said Catalent ...
Tags: Qsymia capsules, extended-release topiramate, combination therapy